Literature DB >> 21880109

The effect of smoking cessation counselling in pregnant women: a meta-analysis of randomised controlled trials.

K B Filion1, H A Abenhaim, S Mottillo, L Joseph, A Gervais, J O'Loughlin, G Paradis, R Pihl, L Pilote, S Rinfret, M Tremblay, M J Eisenberg.   

Abstract

BACKGROUND: Pregnant smokers are often prescribed counselling as part of multicomponent cessation interventions. However, the isolated effect of counselling in this population remains unclear, and individual randomised controlled trials (RCTs) are inconclusive.
OBJECTIVE: To conduct a meta-analysis of RCTs examining counselling in pregnant smokers. SEARCH STRATEGY: We searched the CDC Tobacco Information and Prevention, Cochrane Library, EMBASE, Medline and PsycINFO databases for RCTs evaluating smoking cessation counselling. SELECTION CRITERIA: We included RCTs conducted in pregnant women in which the effect of counselling could be isolated and those that reported biochemically validated abstinence at 6 or 12 months after the target quit date. DATA COLLECTION AND ANALYSIS: Overall estimates were derived using random effects meta-analysis models. MAIN
RESULTS: Our search identified eight RCTs (n = 3290 women), all of which examined abstinence at 6 months. The proportion of women that remained abstinent at the end of follow up was modest, ranging from 4 to 24% among those randomised to counselling and from 2 to 21% among control women. The absolute difference in abstinence reached a maximum of only 4%. Summary estimates are inconclusive because of wide confidence intervals, albeit with little evidence to suggest that counselling is efficacious at promoting abstinence (odds ratio 1.08, 95% confidence interval 0.84-1.40). There was no evidence to suggest that efficacy differed by counselling type.
CONCLUSIONS: Available data from RCTs examining the isolated effect of smoking cessation counselling in pregnant women are limited but sufficient to rule out large treatment effects. Future RCTs should examine pharmacological therapies in this population.
© 2011 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2011 RCOG.

Entities:  

Mesh:

Year:  2011        PMID: 21880109     DOI: 10.1111/j.1471-0528.2011.03065.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  19 in total

Review 1.  Pulmonary Effects of Maternal Smoking on the Fetus and Child: Effects on Lung Development, Respiratory Morbidities, and Life Long Lung Health.

Authors:  Cindy T McEvoy; Eliot R Spindel
Journal:  Paediatr Respir Rev       Date:  2016-08-19       Impact factor: 2.726

2.  Postnatal Cardiovascular Consequences in the Offspring of Pregnant Rats Exposed to Smoking and Smoking Cessation Pharmacotherapies.

Authors:  Kathirvel Gopalakrishnan; Amar S More; Gary D Hankins; Tatiana N Nanovskaya; Sathish Kumar
Journal:  Reprod Sci       Date:  2016-10-12       Impact factor: 3.060

3.  The Role of Nicotine in the Effects of Maternal Smoking during Pregnancy on Lung Development and Childhood Respiratory Disease. Implications for Dangers of E-Cigarettes.

Authors:  Eliot R Spindel; Cindy T McEvoy
Journal:  Am J Respir Crit Care Med       Date:  2016-03-01       Impact factor: 21.405

4.  Contingency Management Versus Psychotherapy for Prenatal Smoking Cessation: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Sarah M Wilson; Amie R Newins; Alyssa M Medenblik; Nathan A Kimbrel; Eric A Dedert; Terrell A Hicks; Lydia C Neal; Jean C Beckham; Patrick S Calhoun
Journal:  Womens Health Issues       Date:  2018-07-27

5.  Vitamin C to Decrease the Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP): Rationale, design, and methods of a randomized, controlled trial of vitamin C supplementation in pregnancy for the primary prevention of effects of in utero tobacco smoke exposure on infant lung function and respiratory health.

Authors:  Cindy T McEvoy; Kristin F Milner; Ashley J Scherman; Diane G Schilling; Christina J Tiller; Brittany Vuylsteke; Lyndsey E Shorey-Kendrick; Eliot R Spindel; Robert Schuff; Julie Mitchell; Dawn Peters; Jill Metz; David Haas; Keith Jackson; Robert S Tepper; Cynthia D Morris
Journal:  Contemp Clin Trials       Date:  2017-05-08       Impact factor: 2.226

6.  Cost effectiveness of vitamin c supplementation for pregnant smokers to improve offspring lung function at birth and reduce childhood wheeze/asthma.

Authors:  Leah Yieh; Cindy T McEvoy; Scott W Hoffman; Aaron B Caughey; Kelvin D MacDonald; Dmitry Dukhovny
Journal:  J Perinatol       Date:  2018-05-22       Impact factor: 2.521

7.  Oral Vitamin C (500 mg/d) to Pregnant Smokers Improves Infant Airway Function at 3 Months (VCSIP). A Randomized Trial.

Authors:  Cindy T McEvoy; Lyndsey E Shorey-Kendrick; Kristin Milner; Diane Schilling; Christina Tiller; Brittany Vuylsteke; Ashley Scherman; Keith Jackson; David M Haas; Julia Harris; Robert Schuff; Byung S Park; Annette Vu; Dale F Kraemer; Julie Mitchell; Jill Metz; David Gonzales; Carol Bunten; Eliot R Spindel; Robert S Tepper; Cynthia D Morris
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

Review 8.  Tobacco Use and Smoke Exposure in Children: New Trends, Harm, and Strategies to Improve Health Outcomes.

Authors:  Luv D Makadia; P Jervey Roper; Jeannette O Andrews; Martha S Tingen
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

9.  Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index.

Authors:  Hannah H Chang; Jim Larson; Hannah Blencowe; Catherine Y Spong; Christopher P Howson; Sarah Cairns-Smith; Eve M Lackritz; Shoo K Lee; Elizabeth Mason; Andrew C Serazin; Salimah Walani; Joe Leigh Simpson; Joy E Lawn
Journal:  Lancet       Date:  2012-11-16       Impact factor: 79.321

10.  Dichotomous effects of aryl hydrocarbon receptor (AHR) activation on human fetoplacental endothelial cell function.

Authors:  Anna Palatnik; Hong Xin; Emily J Su
Journal:  Placenta       Date:  2016-06-11       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.